Recruiting Mantle Cell Lymphoma Studies in Duarte
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
This phase III trial tests whether continuous or intermittent zanubrutinib after achieving a complete remission (CR) with rituximab works in older adult patients with mantle cell lymphoma (MCL) who ha...
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
The purpose of this study is to evaluate the efficacy of glofitamab monotherapy compared with an investigator's choice of either rituximab plus bendamustine (BR), or lenalidomide with rituximab (R-Len...
Glofitamab With Obinutuzumab, Venetoclax, and Lenalidomide for the Treatment of Patients With Newly Diagnosed High Risk Mantle Cell Lymphoma
This phase I/II trial tests the safety and effectiveness of glofitamab (with obinutuzumab pretreatment), venetoclax, and lenalidomide in treating patients with newly diagnosed, high risk mantle cell l...
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
The purpose of this study is to determine if giving an experimental drug called venetoclax in combination with lenalidomide and rituximab is safe and effective for treating people with Mantle Cell Lym...
Nemtabrutinib With Rituximab for the Treatment of Patients With Mantle Cell Lymphoma
This phase II trial tests how well nemtabrutinib works with rituximab for the treatment of patients with mantle cell lymphoma. Nemtabrutinib is in a class of medications called kinase inhibitors. It b...
About Mantle Cell Lymphoma Clinical Trials in Duarte
Mantle cell lymphoma (MCL) is a rare, aggressive type of non-Hodgkin lymphoma that develops from B-cells in the mantle zone of lymph nodes. It accounts for about 5-7% of all NHL cases. Treatment includes combination chemotherapy, targeted therapy, and stem cell transplant.
There are currently 5 mantle cell lymphoma clinical trials recruiting participants in Duarte, CALIFORNIA. These studies are seeking a combined 708 participants. Research is being sponsored by Alliance for Clinical Trials in Oncology, Hoffmann-La Roche, City of Hope Medical Center. Clinical trial participation is free and participants receive study-related medical care at no cost.
Mantle Cell Lymphoma Clinical Trials in Duarte — FAQ
Are there mantle cell lymphoma clinical trials in Duarte?
Yes, there are 5 mantle cell lymphoma clinical trials currently recruiting in Duarte, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Duarte?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Duarte research site will contact you about next steps.
Are clinical trials in Duarte free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Duarte studies also compensate for your time and travel.
What mantle cell lymphoma treatments are being tested?
The 5 active trials in Duarte are testing new therapies including novel drugs, biologics, and treatment approaches for mantle cell lymphoma.
Data updated March 2, 2026 from ClinicalTrials.gov